Xiao, Hong
Bertwistle, David
Khela, Keerun
Middleton-Dalby, Chloe
Hall, Jennifer
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 21 June 2022
Accepted: 16 January 2023
First Online: 23 February 2023
Declarations
:
: This research complied with all relevant market research guidelines and legal obligations, and data were collected according to European Pharmaceutical Marketing Research Association (EphMRA) guidelines [CitationRef removed]. This research also obtained ethics approval from the Western Institutional Review Board, Inc., study protocol number 1–1167678-1. Each survey was performed in full compliance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 and Health Information Technology for Economic and Clinical Health Act legislation [CitationRef removed]. Patients provided informed consent for use of their anonymized and aggregated data for research and publication in scientific journals.
: Not applicable.
: Jennifer Hall is an employee of Adelphi Real World and has no conflict of interest to declare. Chloe Middleton-Dalby and Keerun Khela were employees of Adelphi Real World at the time the study was conducted and had no conflict of interest to declare.Hong Xiao and David Bertwistle are employees of Bristol Myers Squibb.